Albemarle Co. (ALB) Receives Average Rating of “Buy” from Analysts

Shares of Albemarle Co. (NYSE:ALB) have received an average rating of “Buy” from the twenty-four brokerages that are presently covering the firm, MarketBeat reports. Ten analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $125.75.

Several equities research analysts have recently weighed in on the company. UBS Group increased their price objective on Albemarle from $123.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, November 9th. Jefferies Group reissued a “buy” rating on shares of Albemarle in a report on Tuesday, October 24th. BMO Capital Markets assumed coverage on Albemarle in a report on Tuesday, October 24th. They issued an “outperform” rating and a $160.00 price objective for the company. Zacks Investment Research downgraded Albemarle from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Finally, Loop Capital set a $150.00 price objective on Albemarle and gave the company a “buy” rating in a report on Tuesday, December 19th.

A number of institutional investors have recently added to or reduced their stakes in the business. William Blair Investment Management LLC lifted its holdings in Albemarle by 13.7% in the fourth quarter. William Blair Investment Management LLC now owns 31,709 shares of the specialty chemicals company’s stock valued at $4,055,000 after acquiring an additional 3,828 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Albemarle by 62.7% in the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 5,971 shares of the specialty chemicals company’s stock valued at $764,000 after buying an additional 2,300 shares in the last quarter. WealthPLAN Partners LLC purchased a new position in shares of Albemarle in the fourth quarter valued at $1,598,000. Slow Capital Inc. purchased a new position in shares of Albemarle in the fourth quarter valued at $898,000. Finally, Banco de Sabadell S.A purchased a new position in shares of Albemarle in the fourth quarter valued at $133,000. 87.23% of the stock is owned by institutional investors.

Albemarle (NYSE ALB) traded up $2.53 during mid-day trading on Tuesday, hitting $114.77. The stock had a trading volume of 430,176 shares, compared to its average volume of 2,470,000. The firm has a market capitalization of $12,680.00, a P/E ratio of 40.99, a P/E/G ratio of 1.48 and a beta of 1.56. Albemarle has a 1-year low of $91.02 and a 1-year high of $144.99. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.thelincolnianonline.com/2018/02/20/albemarle-co-alb-receives-average-rating-of-buy-from-analysts.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply